L

Researcher Profile

Laurence Krieger

4

Publications

413

Citations

10

Co-Authors

3

Active Years

Publications

Open Access Journal Article European Urology Feb 01, 2026

Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin–naïve Non–muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301)

Dickon Hayne · Alison Y. Zhang · Hayley Thomas · Laurence Krieger +23 more

10.1016/j.eururo.2026.01.009 2 citations

Journal Article The Lancet Oncology May 01, 2024

[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial

Louise Emmett · Shalini Subramaniam · Megan Crumbaker · Andrew Nguyen +35 more

10.1016/s1470-2045(24)00135-9 134 citations

Journal Article Journal of Clinical Oncology Dec 20, 2024

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Fred Saad · Egils Vjaters · Neal Shore · David Olmos +169 more

10.1200/jco-24-01798 114 citations

Journal Article The Lancet Oncology Apr 01, 2023

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

Christopher J Sweeney · Andrew J Martin · Martin R Stockler · Stephen Begbie +96 more

10.1016/s1470-2045(23)00063-3 163 citations

Publication Timeline

2026

1

2024

2

2023

1

Frequent Co-Authors

Andrew Weickhardt

Amanda Stevanovic

Patricia Bastick

Margaret McJannett